Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE

Carol L. Vanderlugt, Nitin J. Karandikar, Deborah J. Lenschow, Mauro C. Dal Canto, Jeffrey A. Bluestone, Stephen D. Miller

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

PLP139-151-induced experimental autoimmune encephalomyelitis in the SJL mouse is a Th1-mediated inflammatory demyelinating disease characterized by a relapsing-remitting clinical course (R-EAE). Clinical relapses are mediated by T cells specific for a non-cross reactive secondary PLP epitope (PLP178- 191) induced by epitope spreading. We have previously shown that B7-1 expression is upregulated in SJL mice undergoing R-EAE and in vivo treatment during remission with F(ab) fragments of anti-B7-1 mAb, blocked epitope spreading and disease progression. In contrast, the present study shows that treatment with intact anti-B7-1 mAb exacerbated clinical disease relapses and enhanced CNS demyelination. Anti-B7-1-treated mice showed enhanced in vivo delayed-type hypersensitivity (DTH) to the relapse-associated PLP178-191 epitope and responses to the immunodominant MBP84-104 epitope which are absent in the controls. Thus, ligation of B7-1 by intact mAbs has effects opposite to those of anti-B7-1 F(ab) fragments suggesting that the mAb is directly signaling through B7-1 expressed on T cells and/or APCs.

Original languageEnglish (US)
Pages (from-to)113-118
Number of pages6
JournalJournal of Neuroimmunology
Volume79
Issue number2
DOIs
StatePublished - Nov 1997

Fingerprint

Epitopes
Recurrence
Demyelinating Diseases
T-Lymphocytes
Autoimmune Experimental Encephalomyelitis
Delayed Hypersensitivity
Ligation
Disease Progression
galiximab

Keywords

  • B7-1
  • Epitope spreading
  • Experimental autoimmune encephalomyelitis
  • Proteolipid protein
  • SJL/J mice
  • T cell costimulation

ASJC Scopus subject areas

  • Immunology
  • Clinical Neurology
  • Immunology and Allergy
  • Neurology

Cite this

Vanderlugt, C. L., Karandikar, N. J., Lenschow, D. J., Dal Canto, M. C., Bluestone, J. A., & Miller, S. D. (1997). Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE. Journal of Neuroimmunology, 79(2), 113-118. https://doi.org/10.1016/S0165-5728(97)00108-2

Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE. / Vanderlugt, Carol L.; Karandikar, Nitin J.; Lenschow, Deborah J.; Dal Canto, Mauro C.; Bluestone, Jeffrey A.; Miller, Stephen D.

In: Journal of Neuroimmunology, Vol. 79, No. 2, 11.1997, p. 113-118.

Research output: Contribution to journalArticle

Vanderlugt, CL, Karandikar, NJ, Lenschow, DJ, Dal Canto, MC, Bluestone, JA & Miller, SD 1997, 'Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE', Journal of Neuroimmunology, vol. 79, no. 2, pp. 113-118. https://doi.org/10.1016/S0165-5728(97)00108-2
Vanderlugt, Carol L. ; Karandikar, Nitin J. ; Lenschow, Deborah J. ; Dal Canto, Mauro C. ; Bluestone, Jeffrey A. ; Miller, Stephen D. / Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE. In: Journal of Neuroimmunology. 1997 ; Vol. 79, No. 2. pp. 113-118.
@article{a66d44a5aba44f9dac7baaeade10a7eb,
title = "Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE",
abstract = "PLP139-151-induced experimental autoimmune encephalomyelitis in the SJL mouse is a Th1-mediated inflammatory demyelinating disease characterized by a relapsing-remitting clinical course (R-EAE). Clinical relapses are mediated by T cells specific for a non-cross reactive secondary PLP epitope (PLP178- 191) induced by epitope spreading. We have previously shown that B7-1 expression is upregulated in SJL mice undergoing R-EAE and in vivo treatment during remission with F(ab) fragments of anti-B7-1 mAb, blocked epitope spreading and disease progression. In contrast, the present study shows that treatment with intact anti-B7-1 mAb exacerbated clinical disease relapses and enhanced CNS demyelination. Anti-B7-1-treated mice showed enhanced in vivo delayed-type hypersensitivity (DTH) to the relapse-associated PLP178-191 epitope and responses to the immunodominant MBP84-104 epitope which are absent in the controls. Thus, ligation of B7-1 by intact mAbs has effects opposite to those of anti-B7-1 F(ab) fragments suggesting that the mAb is directly signaling through B7-1 expressed on T cells and/or APCs.",
keywords = "B7-1, Epitope spreading, Experimental autoimmune encephalomyelitis, Proteolipid protein, SJL/J mice, T cell costimulation",
author = "Vanderlugt, {Carol L.} and Karandikar, {Nitin J.} and Lenschow, {Deborah J.} and {Dal Canto}, {Mauro C.} and Bluestone, {Jeffrey A.} and Miller, {Stephen D.}",
year = "1997",
month = "11",
doi = "10.1016/S0165-5728(97)00108-2",
language = "English (US)",
volume = "79",
pages = "113--118",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE

AU - Vanderlugt, Carol L.

AU - Karandikar, Nitin J.

AU - Lenschow, Deborah J.

AU - Dal Canto, Mauro C.

AU - Bluestone, Jeffrey A.

AU - Miller, Stephen D.

PY - 1997/11

Y1 - 1997/11

N2 - PLP139-151-induced experimental autoimmune encephalomyelitis in the SJL mouse is a Th1-mediated inflammatory demyelinating disease characterized by a relapsing-remitting clinical course (R-EAE). Clinical relapses are mediated by T cells specific for a non-cross reactive secondary PLP epitope (PLP178- 191) induced by epitope spreading. We have previously shown that B7-1 expression is upregulated in SJL mice undergoing R-EAE and in vivo treatment during remission with F(ab) fragments of anti-B7-1 mAb, blocked epitope spreading and disease progression. In contrast, the present study shows that treatment with intact anti-B7-1 mAb exacerbated clinical disease relapses and enhanced CNS demyelination. Anti-B7-1-treated mice showed enhanced in vivo delayed-type hypersensitivity (DTH) to the relapse-associated PLP178-191 epitope and responses to the immunodominant MBP84-104 epitope which are absent in the controls. Thus, ligation of B7-1 by intact mAbs has effects opposite to those of anti-B7-1 F(ab) fragments suggesting that the mAb is directly signaling through B7-1 expressed on T cells and/or APCs.

AB - PLP139-151-induced experimental autoimmune encephalomyelitis in the SJL mouse is a Th1-mediated inflammatory demyelinating disease characterized by a relapsing-remitting clinical course (R-EAE). Clinical relapses are mediated by T cells specific for a non-cross reactive secondary PLP epitope (PLP178- 191) induced by epitope spreading. We have previously shown that B7-1 expression is upregulated in SJL mice undergoing R-EAE and in vivo treatment during remission with F(ab) fragments of anti-B7-1 mAb, blocked epitope spreading and disease progression. In contrast, the present study shows that treatment with intact anti-B7-1 mAb exacerbated clinical disease relapses and enhanced CNS demyelination. Anti-B7-1-treated mice showed enhanced in vivo delayed-type hypersensitivity (DTH) to the relapse-associated PLP178-191 epitope and responses to the immunodominant MBP84-104 epitope which are absent in the controls. Thus, ligation of B7-1 by intact mAbs has effects opposite to those of anti-B7-1 F(ab) fragments suggesting that the mAb is directly signaling through B7-1 expressed on T cells and/or APCs.

KW - B7-1

KW - Epitope spreading

KW - Experimental autoimmune encephalomyelitis

KW - Proteolipid protein

KW - SJL/J mice

KW - T cell costimulation

UR - http://www.scopus.com/inward/record.url?scp=0030775998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030775998&partnerID=8YFLogxK

U2 - 10.1016/S0165-5728(97)00108-2

DO - 10.1016/S0165-5728(97)00108-2

M3 - Article

C2 - 9394783

AN - SCOPUS:0030775998

VL - 79

SP - 113

EP - 118

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 2

ER -